Aviv Biomedical, Inc.
| 750 VASSAR AVE
LAKEWOOD, NJ, -
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|
DESCRIPTION (provided by applicant): Uncontrolled hyperbilirubinemia (jaundice) in neonates has long been known to lead to neurological dysfunction including irreversible athetoid cerebral palsy with ...SBIR Phase II 2012 Department of Health and Human Services
DESCRIPTION (provided by applicant): Human serum albumin is capable of binding bilirubin with high affinity, thus sequestering it and mitigat- ing its harmful neurological effects in jaundiced newborn ...SBIR Phase I 2010 Department of Health and Human Services
DESCRIPTION (provided by applicant): The purpose of this STTR is to produce a commercially available rapid-scan absorbance optical detection system for XLA/I analytical ultracentrifuges. The currently ...STTR Phase I 2005 Department of Health and Human Services